pLV-HNF4A-FOXA2-FOXA3 Citations (1)

Originally described in: 3D scaffold-free microlivers with drug metabolic function generated by lineage-reprogrammed hepatocytes from human fibroblasts.
Lu Z, Priya Rajan SA, Song Q, Zhao Y, Wan M, Aleman J, Skardal A, Bishop C, Atala A, Lu B Biomaterials. 2021 Feb;269:120668. doi: 10.1016/j.biomaterials.2021.120668. Epub 2021 Jan 8. PubMed Journal

---

Articles Citing pLV-HNF4A-FOXA2-FOXA3

Articles
Constitutive AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4alpha activity. Sun Z, Linares B, Urdiales C, Alsarmi F, Sang B, Putluri N, Van Nostrand JL. Sci Adv. 2026 Apr 10;12(15):eaea8017. doi: 10.1126/sciadv.aea8017. Epub 2026 Apr 10. PubMed

If you have published an article using this material, please email us at to have your article added to this page.